Table 2.
Summary of the types of implanted medical materials, presence of artefacts in positron emission tomography (PET)/MRI and PET/CT and their effects on the estimation of 18F-fludeoxyglucose (18F-FDG) PET uptake based on qualitative assessment
| Patient number | Implanted device type | Presence of artefact |
Effect on [18F]-FDG uptake estimation |
|||
| CT | MRI | MRAC | PETCTAC | PETMRAC | ||
| 1 | Dental | + | + | − | ↓ | ↓ |
| 2 | Dental | + | + | + | ↑ | ↓ |
| 4 | Dental | + | − | − | − | − |
| 4 | Dental | + | − | − | − | − |
| 5 | Dental | + | + | + | ↑ | ↓ |
| 5 | Dental | + | − | − | ↑ | − |
| 6 | Dental | + | − | − | ↑ | − |
| 6 | Dental | + | + | + | ↑ | ↓ |
| 7 | Dental | + | + | + | ↑ | ↓ |
| 7 | Dental | + | + | + | ↑ | ↓ |
| 8 | Dental | + | + | + | ↑ | ↓ |
| 8 | Dental | + | − | − | ↑ | − |
| 9 | Dental | + | − | − | ↑ | − |
| 9 | Dental | + | − | − | ↑ | − |
| 10 | Dental | + | + | + | ↑ | ↓ |
| 11 | Dental | + | + | + | ↑ | ↓ |
| 11 | Dental | + | + | + | ↑ | ↓ |
| 11 | Dental | + | − | − | − | − |
| 12 | Dental | + | + | + | ↑ | ↓ |
| 12 | Dental | + | + | + | ↑ | ↓ |
| 1 | Injection port | + | + | + | ↑ | ↓ |
| 5 | Injection port | + | + | + | ↓ | ↓ |
| 6 | Injection port | + | + | − | ↑ | ↓ |
| 11 | Hip prosthesis | + | + | + | ↑ | ↓ |
| 11 | Hip prosthesis | + | + | + | ↑ | ↓ |
| 12 | Hip prosthesis | + | + | + | ↑ | ↓ |
| 8 | Sternal cerclage | + | + | + | ↑ | ↓ |
MRAC, MRI-based attenuation correction; PETCTAC, CT-based attenuation-corrected PET; PETMRAC, MR-based attenuation-corrected PET.
+, yes; −, no; ↓, underestimation of [18F]-FDG uptake; ↑, overestimation of [18F]-FDG uptake.